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Pre-validation methods for developing a patient
reported outcome instrument
Maria E Prior1*, Jemaima Che Hamzah1,2,3, Jillian J Francis1, Craig R Ramsay1, Mayret M Castillo1,
Susan E Campbell4, Augusto Azuara-Blanco1,3 and Jennifer M Burr1,3
Abstract
Background: Measures that reflect patients’ assessment of their health are of increasing importance as outcome
measures in randomised controlled trials. The methodological approach used in the pre-validation development of
new instruments (item generation, item reduction and question formatting) should be robust and transparent. The
totality of the content of existing PRO instruments for a specific condition provides a valuable resource (pool of
items) that can be utilised to develop new instruments. Such ‘top down’ approaches are common, but the explicit
pre-validation methods are often poorly reported. This paper presents a systematic and generalisable 5-step pre-
validation PRO instrument methodology.
Methods: The method is illustrated using the example of the Aberdeen Glaucoma Questionnaire (AGQ). The five
steps are: 1) Generation of a pool of items; 2) Item de-duplication (three phases); 3) Item reduction (two phases); 4)
Assessment of the remaining items’ content coverage against a pre-existing theoretical framework appropriate to
the objectives of the instrument and the target population (e.g. ICF); and 5) qualitative exploration of the target
populations’ views of the new instrument and the items it contains.
Results: The AGQ ‘item pool’ contained 725 items. Three de-duplication phases resulted in reduction of 91, 225
and 48 items respectively. The item reduction phases discarded 70 items and 208 items respectively. The draft AGQ
contained 83 items with good content coverage. The qualitative exploration (’think aloud’ study) resulted in
removal of a further 15 items and refinement to the wording of others. The resultant draft AGQ contained 68
items.
Conclusions: This study presents a novel methodology for developing a PRO instrument, based on three sources:
literature reporting what is important to patient; theoretically coherent framework; and patients’ experience of
completing the instrument. By systematically accounting for all items dropped after the item generation phase, our
method ensures that the AGQ is developed in a transparent, replicable manner and is fit for validation. We
recommend this method to enhance the likelihood that new PRO instruments will be appropriate to the research
context in which they are used, acceptable to research participants and likely to generate valid data.
Background
Measures that reflect patients’ assessment of their health
are of increasing importance as outcome measures in
randomised controlled trials (RCTs). The decision
whether to use a validated patient reported outcome
(PRO) instrument or to develop a new one should be
based on a thorough review of PRO instruments used in
a population of interest [1]. If a new PRO instrument is
required, the methodological approach used in its devel-
opment should be robust and transparent. There are
two main phases in generating a new PRO instrument -
developing the instrument and validating the instru-
ment. Steps for developing a PRO instrument involve
item generation, item reduction and question format-
ting. Validation of the instrument follows, to assess
coherence across the items and inform the removal of
poorly discriminating, unreliable or invalid items [2].
To generate a pool of potentially relevant items for
condition-specific instruments, most studies focus on an
inductive ‘bottom up’ approach using qualitative
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methods (e.g. focus groups or one-to-one interviews
with the target population), which ensures items reflect
the perspective of the majority of individuals in the
population of interest [3,4]. However, data generated
using this approach often reaffirm previous qualitative
findings, resulting in the development of ‘new’ instru-
ments containing items with overlapping, but not identi-
cal content coverage [3-5].
As the catalogue of validated PRO instruments grows
within a clinical specialty, so does the body of empirical
evidence of what is important to patients with that con-
dition (’content’ domains). The body of evidence repre-
sented by the totality of the content of existing PRO
instruments for a specific condition may provide a valu-
able resource (pool of items) that can be utilised to
develop new PRO instruments. Such ‘top down’
approaches, using expert opinion and/or the published
literature in the field, are common [6] but the explicit
methods used in the item generation and item reduction
stages are often poorly reported [7,8].
To address the lack of explicit methods for item gen-
eration and reduction, this paper presents a 5-step
methodology for the pre-validation stages of PRO
instrument development (i.e. item generation, item
reduction and question formatting). The method is illu-
strated using the example of the Aberdeen Glaucoma
Questionnaire (AGQ), a new instrument designed to be
used for a future randomised controlled trial (RCT)
evaluating the effectiveness of glaucoma screening com-
pared with no formal screening (opportunistic case
detection)
Methods
Example instrument - Aberdeen Glaucoma Questionnaire
The aim of the AGQ is to compare patient reported
vision related disability between the intervention (glau-
coma screening) and comparator (opportunistic case
detection) arms at the end of a proposed RCT. In
ophthalmology there are high quality validated vision
and glaucoma PRO instruments covering a wide range
of content (e.g. visual impairment, visual symptoms,
treatment satisfaction, activity and participation difficul-
ties) [9]. However, existing instruments used in glau-
coma populations are not suitable in their entirety for
evaluating screening interventions because the trial
population includes people with and without a diagnosis
[9]. In addition, within a screening trial context it is also
important to compare other health effects between the
screened and unscreened population to capture any
wider benefits or harms of screening. Existing generic
instruments are adequate for this purpose and can be
used alongside condition-specific measures. Given this
context, we proposed to build on previous research by
making use of the existing body of knowledge in terms
of items that are known to be relevant to people with
glaucoma and to develop a new instrument from these.
Table 1 presents the five steps involved in the pre-
validation PRO development methodology. Steps 1 to 3
involve the synthesis of the products of research (i.e.
validated PRO instruments). The items that result from
the systematic application of these steps form the basis
of a new condition-specific PRO instrument. Step 4
involves assessment of the content coverage of items
retained after Step 3 against a pre-existing theoretical
framework appropriate to the objectives of the instru-
ment and the target population. This process provides
clarity on the dimensions of health covered in the new
PRO instrument (i.e. how well the construct under mea-
surement is represented by an instrument). Step 5 com-
prises a qualitative exploration of the target populations’
views of the new instrument and the items it contains.
1. Item generation for the AGQ
a) We selected instruments from PRO instruments used
in a glaucoma context (generic, vision- and glaucoma-
specific) that had been systematically identified as part
of a wider study assessing instrument quality [9] using
the following eligibility criteria: suitable for self report;
validated in a glaucoma population; in the public
domain; items and response options fully described in
the text article reporting the instrument. The total con-
tent of the selected instruments provided a comprehen-
sive pool of items, relevant to people with glaucoma,
from which to select the ‘best’ combination of items to
meet the specific scope of a new instrument.
b) The widely validated generic measure SF-36 was
added to the list of selected instruments as it would be
administered alongside the glaucoma-specific AGQ, in
the proposed trial.
c) A database consisting of all items from the selected
instruments (item pool) was created with items grouped
according to content (e.g. reading, driving, walking). All
information relating to the instrument of origin, the
item and response option content and wording was
retained.
2. Item de-duplication for the AGQ
We conducted three phases of de-duplication (A, B, C)
in the development of the draft AGQ.
A) In the first de-duplication task, three pairs of
reviewers from the multi-disciplinary research team
(health services researchers, health psychologists and
ophthalmologists) independently assessed one third of
all items for literal duplications. Literal duplication was
defined as identically worded items (including time-
frame), or items which, in each reviewer’s opinion,
asked the same question (but may be worded differently)
and which, if both were included in the AGQ, would
represent duplication of content. One researcher (MP)
collated decisions from each pair of reviewers. Items for
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which there was reviewer agreement were reduced to a
single item in the item pool, with all other information
retained (i.e. instrument of origin, response options and
unique item number). Any reviewer disagreements were
resolved by consensus or arbitration by JB (clinical aca-
demic (ophthalmology)).
B) The second phase of item de-duplication involved
grouping together all items that referred to the same
aspect of a specific content theme (e.g. loneliness), but
which differed in timeframe or in whether they included
an attribution of action to eyesight (e.g. do you feel
alone? versus in the past month have you felt lonely or
isolated because of your eyesight?). Such items were
grouped together and the wording of all individual items
within each group was retained. The purpose of this
phase of de-duplication was to retain all aspects of all
content themes within the item pool, whilst acknowled-
ging that only one item per group would ultimately be
chosen for inclusion in the AGQ.
C) The third phase of de-duplication identified item
content overlap between the SF-36 items and other items
in the pool. All SF-36 items and any extra items consid-
ered, by the multi-disciplinary team, to be directly cov-
ered by SF-36 items were removed from the item pool.
3. Item reduction for the AGQ
Two phases of item reduction (D and E) were con-
ducted to determine which items were retained in the
draft AGQ.
D) The first phase of item reduction consisted of a
‘macro level’ removal of items relating to content
themes that were not appropriate for inclusion in the
AGQ; a self-report measure of vision related disability.
Decisions regarding the removal of all items within a
content theme (e.g. treatment satisfaction) were
informed by the literature and by the multi-disciplinary
research team including the clinical opinion of the three
ophthalmologists involved in the project.
E) All items remaining after Phase D covered content
themes (e.g. driving, reading, using public transport)
relevant to vision related disability associated with glau-
coma. However, the specific wording of many of these
items made them unsuitable for inclusion in the draft
AGQ. Explicit criteria were applied to identify items for
removal. All items that were not applicable to people
without a diagnosis of glaucoma were removed. As were
items referring to ‘frequency of’ rather than ‘difficulty
with’ performing an activity (e.g. driving). Items relating
to very specific tasks (e.g. difficulty threading a needle)
were removed to reduce participant burden and to
accommodate the inclusion of similar, but more widely
applicable items (e.g. difficulty with tasks that require
you to see up close). Item quality was assessed by the
multi-disciplinary team. Items with poor reading ease
and/or potential ambiguity were removed (e.g. “Do you
hit persons or objects?”). Following phase E of the item
reduction, the wording of the remaining items was
adapted to maximise consistency of both item wording
and response format. Items were then formatted as the
draft AGQ.
4. Assessing AGQ content coverage against a pre-existing
theoretical framework
We used the World Health Organisation (WHO) Inter-
national Classification of Functioning, Disability and
Health (ICF) [10] to assess the content coverage of the
AGQ. The ICF provides a framework within which item
content can be systematically coded using a standardised
common language [10] thus providing clarity on how
well the construct under measurement (i.e. vision
related disability associated with glaucoma) is repre-
sented within the AGQ. The ICF takes into account the
social aspects, not just the medical or biological aspects
of disability, and defines four components of functioning
and disability: Body Structures, Body Functions, Activ-
ities and Participation [10]. In addition, the ICF contains
Table 1 5-step PRO development methodology
Step
1
Item generation:
a. Systematic identification of existing PRO instruments meeting explicit eligibility criteria.
b. Selection of additional instruments (e.g. generic instruments) to be administered alongside the new PRO instrument.
c. All items from the identified instruments form the initial ‘item pool’ (to which Steps 2-5 are applied).
Step
2
Item de-duplication. Items are discarded if:
A) They are literal duplications (identically worded items, or duplication of item content)
B) Their content differs only by timeframe or attribution to a condition of interest (e.g. do you have difficulty... because of your condition)
C) Their content overlaps with generic measures to be administered alongside new instrument (e.g. SF-36)
Step
3
Item reduction:
D) Macro level: items discarded if associated with content themes (dimensions of health) that are not appropriate for inclusion in the new
instrument (e.g. treatment satisfaction)
E) Micro level: application of explicit, study-relevant criteria to select items for inclusion in draft instrument (actual content area)
Step
4
Assessment of content coverage against a relevant pre-existing theoretical framework (revisit 3E if content coverage suboptimal)
Step
5
Exploratory pilot work with target population to assess comprehensibility, acceptability, relevance and answerability in order to inform
instrument refinement (item removal &/or re-wording) (e.g.’think aloud’ study, focus groups)
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contextual Environmental Factors (i.e. physical, attitudi-
nal and social factors) and Personal Factors (e.g. age,
gender) that might influence functioning and disability.
The content of each included item in the draft AGQ
was assessed for its coverage of ICF components and
contextual factors using the linking rules developed by
Cieza and colleagues (2005) [11]. This process involves
first identifying the meaningful concepts (i.e. the ideas or
information) contained within each item in the AGQ.
These might relate to body structures (e.g. the eye) or
functions (e.g. seeing) or to activities (e.g. walking) or to
participation in a life situation (e.g. using public trans-
port). Each meaningful concept is then linked to the
most precise ICF category and coded accordingly (e.g.
visual field = b2101, light intensity = e2400) [10].
5. Exploratory pilot work - A ‘think aloud’ study
The ‘think aloud’ technique (cognitive interviewing) is a
valuable method for gaining insights into people’s
thought processes whilst undertaking a task [12]. The
technique is commonly used during questionnaire devel-
opment to determine whether the meaning of an item,
as intended by the questionnaire developer, is consistent
with the respondent’s interpretation of that item [13]. A
‘think aloud’ study was conducted to explore glaucoma
patients’ views on the comprehensibility, acceptability,
relevance and answerability of the draft AGQ in order
to inform its refinement. Ethical approval was obtained
from the North of Scotland Research Ethics Committee
(Ref: 09/S0801/41)
Participants consisted of a purposive sample of eight
patients with differing severities of glaucoma (two each
with mild, moderate or severe glaucoma and two with
no visual impairment). Each participant completed the
AGQ, in the presence of a researcher (MC), who asked
them to verbalise their thoughts (’think aloud’) whilst
completing a paper version of the draft AGQ. In addi-
tion, MC probed patients’ comments about specific
items and ascertained their opinions about the AGQ in
general (e.g. content, format, length). Interviews were
audio-recorded and transcribed verbatim. Verbal
responses to each item were tabulated alongside a parti-
cipant’s written response to that item to identify possi-
ble impact of item interpretation on written responses.
We used an ‘item centred’ coding scheme based on
Tourangeau’s Cognitive Aspect of Survey Methodology
Framework to identify ‘problem’ items (i.e. those with
which participants had difficulty following instructions
or problems with comprehensibility, acceptability, rele-
vance or answerability) [14]. MC coded all transcripts
and MP double coded two transcripts (25% of the data).
Disagreements were resolved by consensus of the ‘think
aloud’ research team (MC, MP, JF, JB). The ‘think aloud’
findings informed the refinement of the AGQ.
Results
Figure 1 presents an overview of the results in the devel-
opment of the AGQ. Each of the steps represented in
Figure 1 is described in detail below.
1. Item generation for the AGQ
The systematic review of PRO instruments used in the
glaucoma populations identified 34 vision- or glaucoma-
specific instruments and 7 generic instruments [9].
From these, we selected the 20 instruments (17 vision-
specific, 3 generic) that met the selection criteria for
inclusion in the item pool [15-34] (see Table 2). In addi-
tion, we included the SF-36 [35] in the selected instru-
ments as it was to be an outcome measure in the
proposed screening trial and including it allowed us to
use these systematic methods to avoid duplication of
content coverage between the SF-36 and items from
other instruments.
The deconstruction of eligible instruments and the SF-
36 into constituent items generated an item pool of 725
items (Figure 1). When considered together, the total
content of these 20 instruments provides a large assort-
ment of items relevant to people with glaucoma. An
extract from the item pool is shown in Table 3.
2. Item de-duplication for the AGQ
Phase A
The literal duplication phase resulted in the reduction of
91 items. For example, Table 4 shows that four instru-
ments include the item “In general would you say your
[overall] health is...”, although response options vary.
The stems of these four items were reduced to a single
item, creating a reduction of three items from the item
total (Table 5). All other information about items 2, 3, 4
and 5 was retained (i.e. instrument of origin, response
option, unique item identification).
Phase B
The grouping of items that refer to the same aspect of a
specific content theme, but which differ in timescale or
attribution of action to eyesight resulted in the reduc-
tion of 225 items. The wording of all such items was
retained, but row borders between them were removed.
For example, two of the three items in Table 6 include
a timescale (153, 68) and Item 68 asks participants to
attribute any loneliness to their eyesight, whilst the
other two do not.
Phase C
The third phase of item de-duplication resulted in the
reduction of 48 items (Figure 1); the 36 items from the
SF-36 and 12 extra items considered to be directly cov-
ered by SF-36 items were removed. For instance, whilst
not a literal duplication or only differing in timescale
and/or attribution, the SF-36 item on bathing and
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dressing was considered to directly cover three items on
dressing from two other instruments (Table 7).
3. Item reduction for the AGQ
Phase D
Decisions on which content themes were not relevant
for inclusion in the AGQ were informed by the litera-
ture and by ophthalmologists on the research team.
Excluded content themes include nausea, hearing,
sleep, personal financial circumstances, treatment
satisfaction and access to health services. This macro
level item reduction (D) resulted in the removal of 70
items.
Phase E
The micro level reduction reduced the remaining 292
items to 83 items. Table 8 shows four such items
removed in phase E. Although the content coverage of
these items is relevant for inclusion in the AGQ, they
relate to the performance of very specific tasks and were
removed to reduce participant burden and to accommo-
date the inclusion of other, more widely applicable,
items.
4. Linking AGQ content to the ICF
The 83 items in the initial version of the AGQ origi-
nated from 16 of the 20 instruments used to generate
the item pool in Step 1a [15,18,19,21-27,29-34]. The
items contained meaningful concepts related to two ICF
categories of Body Structure, eight of Body Function, fif-
teen categories associated with Activity or Participation
and seven categories of Environmental factors. (See
additional file 1: Linking AGQ content to ICF)
Inevitably, with such a collection of 83 items, item
timescales varied in the initial version of the AGQ, as
did response formats and the use of first- and second-
person personal pronouns. Fifty-three of the selected
items were formatted as questions; the others as state-
ments or symptom checklists. This eclectic mix of 83
items represented the ‘best’ combination of content
2A) De-duplication: Literal 
duplication n  = 91
2B) De-duplication: Timescale 
&/or attribution  n = 225
2C) Content overlap 
with SF-36 n  = 48
3D) Item reduction : 
Macro level  n  = 70
3E) Item reduction:  
Micro level n  = 208
Items in draft AGQ n = 83 
5) Refinement following 
exploratory work with target 
population ‘Think Aloud’ 
study  n  = 15
Pre-validation  prototype AGQ n = 68
  
  
 
4) Assessment of theoretical 
coverage (ICF components) n = 0
1) Item generation: Eligible items n  = 725
Figure 1 methodological development of AGQ flowchart.
Table 2 Selected instruments for inclusion in the item
pool
Activities of daily vision scale
[15]
TSS-IOP [16]
Glaucoma Symptom Scale [17] Turano [18]
Glaucoma Quality of Life - 15
[19]
Uenishi [20]
IND VFQ 33 [21] Visual Activities Questionnaire [22]
Impact of Vision Impairment [23] VF-14 [24]
Mills [25] LVQOL [26]
Viswanathan [27] Adapted General Well-Being Index
[28]
NEI-VFQ 25 [29] CES-D [30]
Odberg symptom items [31] SWED-QUAL [32]
QOLVFQ [33] SUMI [34]
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coverage with appropriate theoretical coverage. Item
stem and response option wording was adapted to
increase consistency in the new instrument, but the con-
tent and theoretical coverage of each item accurately
reflected the original (i.e. in terms of meaningful con-
cept). It was this initial draft of the AGQ (with 83
items) that was subjected, in Step 5, to further investiga-
tion using the ‘think aloud’ technique.
5. Results of Think Aloud study
The think-aloud interviews resulted in the removal of
fifteen items from the initial version of the AGQ. Seven
of these were removed due to comprehensibility pro-
blems (i.e. the participant either reported difficulties
with the meaning of words, or they answered the item
in such a way that suggested the item was not under-
stood, or they reported a lack of contextual information
needed to answer the item accurately (e.g. lack of time-
frame). Importantly, the ICF category coverage was not
affected by the removal of these, or any other, items.
Removal of a further four items resulted from partici-
pants’ suggestions of item redundancy (i.e. items cover-
ing difficulty with driving in different contexts were
removed (e.g. driving in the rain at night with oncoming
headlights) in the presence of five other driving items).
The final four items removed resulted from the conden-
sing of two-part items into single items following diffi-
culties experienced by participants with correctly
following re-routing instructions.
In addition to item removal, the think aloud study
findings informed changes to the wording of retained
items to increase consistency of item wording and
minimise participant burden. For example in the initial
version of the AGQ, the word difficulty appeared in
many of the questions (do you have difficulty with...?),
as well as in the corresponding response options (no dif-
ficulty, a little difficulty, moderate difficulty, extreme dif-
ficulty). The word difficulty was removed from the
response options of such items, thus changing the word-
ing of such responses to: no; a little; moderate; extreme.
This change occurred in response to suggestions that
the repetition in wording between question and
response option was unnecessary and irritating.
Summary of results
The systematic identification of 20 self-report instru-
ments used in a glaucoma population and in the public
domain, together with the SF-36, generated a total of
725 items, with extensive content coverage, for inclusion
in an item pool. The application of three phases of de-
duplication and two phases of item reduction resulted
in the removal of a total of 642 items. The remaining 83
items were assessed to have a good breadth of coverage
of ICF components (body structures, body functions,
activity, participation and environment) and formed the
initial draft of the AGQ. Where necessary the wording
and formatting of items was adapted to increase consis-
tency, but the content and theoretical coverage of each
item was maintained. The exploration of comprehensi-
bility, acceptability, relevance and answerability of the
initial draft of the AGQ in a ‘think aloud’ study resulted
in the removal of 15 items and to the refinement of
others. The resultant pre-validation draft AGQ contains
68 items.
Table 3 Extract from item pool illustrating presentation of item-level data
Item
No
Item Response Instrument
257 Do objects ever suddenly appear when you should have
noticed them before?
1 = no, 2 = uncertain, 3 = yes MILLS 1986
258 Does your vision give you any difficulty (even with
glasses) with seeing objects coming from the side?
1 = none, 2 = a little bit, 3 = some, 4 = quite a lot, 5 = severe, 0 =
do not perform for nonvisual reasons
GQL-15
259 Because of your eyesight, how much difficulty do you
have noticing objects off to the side while you are
walking along?
1 = no difficulty at all, 2 = a little difficulty, 3 = moderate difficulty,
4 = extreme difficulty, 5 = stopped doing this because of your
eyesight, 6 = stopped doing this for other reasons or not interested
in doing this
NEI VFQ-25
260 I have trouble noticing things in my peripheral vision. never, rarely, sometimes, often, always VAQ
Table 4 Extract from item pool illustrating presentation of items 2, 3, 4, 5, before literal de-duplication
Item No. Item Response Instrument
2 In general would you say your health is.. 1-4 scale response, higher scores indicating more optimistic views. QOLVFQ
3 In general, would you say your overall health is... 1 = Excellent, 2 = very good, 3 = good, 4 = fair, 5 = poor. NEI VFQ-25
4 In general would you say your health is: 1 = very good, 2 = fairly good, 3 = fair, 4 = rather bad, 5 = very bad SWED-QUAL
5 In general would you say your health is: Excellent, very good, good, fair, poor SF-36
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Discussion
This paper outlines a novel methodological approach
that is applicable to situations where a systematic litera-
ture review has identified numerous high quality vali-
dated instruments (developed using mainly inductive
methods), but where none of the identified instruments
are appropriate to be used, in their current form, to
address the research questions in a particular study. Our
method employs a systematic 5-step approach: 1) Gen-
eration of a pool of items from an existing body of
knowledge; 2) Item de-duplication; 3) Item reduction; 4)
Assessment of content validity (against a relevant pre-
existing theoretical framework); and 5) Exploratory pilot
work to assess comprehensibility, acceptability, relevance
and answerability to the target population. Whilst our 5-
step approach is largely ‘top down’, it differs from other
studies using expert opinion and published literature to
develop PRO instruments in that we systematically uti-
lise the body of empirical evidence amassed from studies
using ‘bottom up’ (qualitative) approaches.
We illustrated our pre-validation method using the
example of the AGQ; a new glaucoma-specific PRO
instrument for use as the primary patient reported out-
come measure for a RCT evaluating the effectiveness of
glaucoma screening. We describe how a large number
of items representing the totality of the content of exist-
ing PRO instruments for a specific condition can be
reduced to those included in a draft PRO instrument
with appropriate content and theoretical coverage, and
ready for validation. The methods we describe are
applicable to the development of other PRO instruments
and more widely to instrument development in other
disciplines.
This paper addresses a methodological gap in the pre-
validation instrument development literature, where
there is a tendency for authors to report, in some detail,
the item generation phase that result from qualitative
work [3,5,36]. However, there are few reports of how a
large number of items generated in early phase work
(using qualitative methods, expert opinion and/or pub-
lished literature) are reduced to those that are included
in the draft PRO instrument used in the validation
process.
The aim of the AGQ is to measure vision related dis-
ability associated with glaucoma and its treatment in a
population screening trial. The use of the ICF as a theo-
retical framework enabled us to identify which aspects
of vision related disability are covered in the AGQ and
the balance of that coverage (i.e. body structures, body
functions, activity and participation). Currently, the
social context of disability is under represented in PRO
instruments (over emphasis on items that measure body
structures and functions) [9]. By contrast, the AGQ pro-
vides good breadth of coverage of ICF components from
both an individual (body structures, body functions and
activities) and societal (participation) perspective. This is
important, if PRO instruments are to serve the purpose
of complementing clinical outcomes (rather than dupli-
cating them from the patients’ perspective).
This study used a subsample of PRO instruments
identified in a wider study assessing instrument quality.
One of the reasons for this was the necessity to con-
struct our item pool from instruments in the public
domain. This inevitably resulted in the exclusion of
valid and reliable instruments with relevant content.
This limitation is unlikely to have had a detrimental
effect on the content coverage of our item pool due to
the diversity of the instruments included in this study
and to the breadth of content and theoretical coverage
of their items.
Table 5 Extract from item pool illustrating presentation of items 2, 3, 4, 5, after literal de-duplication (phase A)
Item No. Item Response Instrument
2 In general would you say your [overall] health is: 1-4 scale response, higher scores indicating more optimistic views. QOLVFQ
3 1 = Excellent, 2 = very good, 3 = good, 4 = fair, 5 = poor. NEI VFQ-25
4 1 = very good, 2 = fairly good, 3 = fair, 4 = rather bad, 5 = very bad SWED-QUAL
5 Excellent, very good, good, fair, poor SF-36
Table 6 Phase B - Example of de-duplication on basis of differing timescale and/or attribution to eyesight
Item
No.
Item Response Instrument
153 During the past week I felt lonely. 0 = rarely or none of the time (less than 1 day); 1 = some or a little of the time (1-
2 days); 2 = occasionally or a moderate amount of the time (3-4 days); 3 = most or
all of the time (5-7 days)
CES-D
154 Do you feel alone? 0 = no, 2 = sometimes, 4 = yes UENISHI
(2003)
68 In the past month have you felt lonely or
isolated because of your eyesight?
not at all, very rarely, a little of the time, a fair amount of the time, a lot of the
time, all of the time.
IVI
Prior et al. BMC Medical Research Methodology 2011, 11:112
http://www.biomedcentral.com/1471-2288/11/112
Page 7 of 9
We do not yet know the psychometric properties of
the AGQ and which, if any, items will be dropped as a
result of a formal validation and assessment of its psy-
chometric properties. However, this is true of all pre-
validation work and does not detract from the impor-
tance of reporting this systematic approach to pre-vali-
dation methodology. The content of the AGQ has been
designed to be acceptable to all participants in a future
RCT evaluating the effectiveness of glaucoma screening
(i.e. applicable to people with and without a diagnosis of
glaucoma). In addition, we anticipate that the optimal
AGQ will be able to discriminate between different
stages of glaucoma severity. By systematically accounting
for all items dropped after the item generation phase,
our method ensures that the AGQ is fit for validation.
The discriminative capabilities (responsiveness) of the
AGQ will be established following formal validation
with a large patient sample and will be reported
elsewhere.
Conclusions
This study presents a novel methodology for developing
a new PRO instrument, based on three sources: litera-
ture that reports what is important to patients (content
coverage) and which provides a body of empirical evi-
dence for item generation; theoretically coherent frame-
work (theoretical coverage); and patients’ experience of
completing the instrument (acceptability). We recom-
mend this to researchers as a transparent and replicable
method that will enhance the likelihood that new PRO
instruments will be appropriate to the research context
in which they are used, acceptable to research partici-
pants and likely to generate valid data.
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